Imatinib Devatis 100 mg (teilbar)

Imatinib Devatis 100 mg (teilbar) is a medicine authorised by Swissmedic under authorisation number 65580. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 October 2015 and the authorisation is valid without a time limit. ATC code L01XE01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 65580
  • ATC L01XE01
  • Synthetic medicines
Authorisation data
Authorisation number65580
NameImatinib Devatis 100 mg (teilbar)
Full nameImatinib Devatis 100 mg (teilbar), Filmtabletten
Authorisation holderDevatis AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01XE01
First authorisation09 October 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Imatinib Devatis 100 mg (teilbar), FilmtablettenA09 October 2015
2Imatinib Devatis 200 mg, FilmtablettenA09 October 2015
3Imatinib Devatis 400 mg, FilmtablettenA09 October 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
730Tablette(n)L01XE0107.16.1.A
860Tablette(n)L01XE0107.16.1.A
930Tablette(n)L01XE0107.16.1.A
1060Tablette(n)L01XE0107.16.1.A
1130Tablette(n)L01XE0107.16.1.A
1260Tablette(n)L01XE0107.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Imatinib Devatis 100 mg (teilbar) authorised in Switzerland?

Yes. Imatinib Devatis 100 mg (teilbar) is authorised by Swissmedic under authorisation number 65580, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Imatinib Devatis 100 mg (teilbar) have?

Imatinib Devatis 100 mg (teilbar) is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Imatinib Devatis 100 mg (teilbar)?

The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com